Live Quote · NASDAQLIMNHealthcare· Biotechnology

Liminatus Pharma, Inc. Class A Common Stock

$2.81
MKT CAP $3.77M
50%
Bullish
TickerSpark Score
30/100
▌ Poor
40
Valuation
20
Profitability
15
Growth
45
Health

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a LIMN research report →

Price Chart

-94.98% · this period
$102.50$52.51$2.52Nov 19May 22Nov 19